Programs
Pharmacotherapy Practice & Principles Special Offer # 10 - Pharmacotherapy Textbook
Date: February 01, 2009 — May 01, 2010
Program Fee:
$100.00
Description
Welcome to our online pharmacotherapy assessment series which corresponds with the textbook Pharmacotherapy Principles and Practice by Dr. Marie Chisholm-Burns, et.al. This series is the complete textbook - all nine series in one In total, the assessment programs allow you to progress through the entire textbook, providing you with up-to-date reviews of all organ systems as well as special disease states and treatment issues. For complete information on the textbook, go to Pharmacotherapy Principles and Practice
Important Note: This of continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. It is available at bookstores and online at:
Amazon
Barnes and Noble
Pharmacotherapy Principles & Practice is unique in many ways including:
Easy-to-follow disorder-based organization that surveys the full range of organ system disorders treated in pharmacy practice
Knowledge-building boxed features within chapters, consisting of Clinical Presentation & Diagnosis, Patient Encounters, and Patient Care and Monitoring Guidelines
A standardized chapter format
Laboratory values expressed in both conventional units and System International (SI) units
Test yourself chapter-by-chapter at your own pace.
This program contains the entire textbook, which includes Chapters 2 – 99 and covers all 1,541 pages of the textbook. The fee for this program is $100.00 and includes the assessment and statement of credit. The University of Georgia College of Pharmacy designates this on-line educational series for a maximum of 170 contact hours (17.0 CEU).
An assessment and course evaluation must be completed for each chapter, then continuing education credit will be awarded and statements issued on-line for successful completion. The multiple choice exams will verify your completion of the course. A passing score of 70 percent is required for credit. You will be given two (2) opportunities to complete each exam. No partial credit will be given. There is no time limit.
You may click "Save Answers" to exit the test and complete later. Your test will not be submitted for grading until you click "Submit Assessment". Check the question box to assure you have answered all questions before you click Submit.
Courses Offered
| Course | Pricing | Contact Hours/CEUs |
|---|---|---|
| Pharmocotherapy Principles and Practice- Hypertension(details) | Included | 3.0/0.3 |
| Pharmocotherapy Principles and Practice- Heart Failure(details) | Included | 4.0/0.4 |
| Pharmocotherapy Principles and Practice- Ischemic Heart Disease(details) | Included | 3.0/0.3 |
| Pharmocotherapy Principles and Practice- Acute Coronary Syndrome(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Arrhythmias(details) | Included | 3.5/0.35 |
| Pharmocotherapy Principles and Practice- Venous Thromboembolism(details) | Included | 3.5/0.35 |
| Pharmocotherapy Principles and Practice- Hyperlipidemia(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Hypovolemic Shock(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Stroke(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Asthma(details) | Included | 3.0/0.3 |
| Pharmocotherapy Principles and Practice- Chronic Obstructive Pulmonary Disease(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Cystic Fibrosis(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Gastroesophageal Reflux Disease(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Peptic Ulcer Disease(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Inflammatory Bowel Disease(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Nausea and Vomiting(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Constipation, Diarrhea, and Irritable Bowel Syndrome(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Portal Hypertension and Cirrhosis(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Pancreatitis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Viral Hepatitis(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Acute Renal Failure(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Chronic and End-Stage Renal Disease(details) | Included | 4.0/0.4 |
| Pharmocotherapy Principles and Practice- Fluids and Electrolytes(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Acid-Base Distubances(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Multiple Sclerosis(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Epilepsy(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Status Epilepticus(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Parkinson's Disease(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Pain Management(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice - Headache(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice - Alzheimer's Disease(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice - Substance-Related Disorders(details) | Included | 3.0/0.3 |
| Pharmocotherapy Principles and Practice- Schizophrenia(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Major Depressive Disorder(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Bipolar Disorder(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Generalized Anxiety Disorder, Panic Disorder, and Social Anxiety Disorder(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Sleep Disorders(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Attention- Deficit Hyperactivity(details) | Included | 0.5/0.1 |
| Pharmocotherapy Principles and Practice- Diabetes Mellitus(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Thyroid Disorders(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Adrenal Gland Disorder(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Pregnancy and Lactation: Therapuetic Considerations(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Contraception(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Menstruation Related Disorders(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Hormone- Replacement Therapy in Menopause(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Erectile Dysfunction(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Benign Prostatic Hyperplasia(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice-Urinary Incontinence and Pediatric Enuresis(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice-Allergic and Pseudo allergic Drug Reactions(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice-Solid-Organ Transplantation(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Osteoporosis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Rheumatoid Arthritis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Osteoarthritis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Gout and Hyperuricemia(details) | Included | 0.5/1.0 |
| Pharmocotherapy Principles and Practice - Musculoskeletal Disorders(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Glaucoma(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Allergic Rhinitis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Minor Ophthalmic Disorders(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Psoriasis(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Common Skin Disorders(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Anemia(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Coagulation Disorders(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice - Sickle Cell Disease(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice - Central Nervous System Infections(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Lower Respiratory Tract Infections(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice - Skin and Soft Tissue Infections(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Infective Endocarditis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Tuberculosis(details) | Included | 1.0/0.1 |
| Pharmacotherapy Practice and Principles - Gastrointestinal Infections(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Intraabdominal Infections(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Parasitic Diseases(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice - Urinary Tract Infection(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Sexually Transmitted Infections(details) | Included | 2.5/0.2 |
| Pharmocotherapy Principles and Practice - Osteomyelitis(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Sepsis and Septic Shock(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice - Superficial Fungal Infections(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Human Immunodeficiency Virus Infection(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Breast Cancer(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Lung Cancer(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Colorectal Cancer(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Prostate Cancer(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Malignant Lymphomas(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Ovarian Cancer(details) | Included | 0.5/0.1 |
| Pharmocotherapy Principles and Practice- Acute Leukemias(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Chronic Leukemias and Multiple Myeloma(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Skin Cancer(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Hematopoietic Cell Transplantation(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Oncologic Emergencies(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Parenteral Nutrition(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Enteral Nutrition(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Overweight and Obesity(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice - Antimicrobial Regimen Selection(details) | Included | 1.5/0.15 |
| Pharmocotherapy Principles and Practice- Invasive Fungal Infections(details) | Included | 2.5/0.25 |
| Pharmocotherapy Principles and Practice- Cancer Chemotherapy and Treatment(details) | Included | 3.0/0.3 |
| Pharmocotherapy Principles and Practice - Upper Respiratory Tract Infections(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Antimicrobial Prophylaxis in Surgery(details) | Included | 1.0/0.1 |
| Pharmocotherapy Principles and Practice- Vaccines and Toxoids(details) | Included | 2.0/0.2 |
| Pharmocotherapy Principles and Practice- Pituitary Gland Disorder(details) | Included | 1.5/0.15 |